Is Serina Therapeutics Stock a good buy in 2025, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NYSEMKT: SER) stock is to Strong Buy SER stock.
Out of 2 analysts, 1 (50%) are recommending SER as a Strong Buy, 1 (50%) are recommending SER as a Buy, 0 (0%) are recommending SER as a Hold, 0 (0%) are recommending SER as a Sell, and 0 (0%) are recommending SER as a Strong Sell.
According to 2 Wall Street analysts that have issued a 1 year SER price target, the average SER price target is $13.00, with the highest SER stock price forecast at $15.00 and the lowest SER stock price forecast at $11.00.
On average, Wall Street analysts predict that Serina Therapeutics's share price could reach $13.00 by Jul 14, 2026. The average Serina Therapeutics stock price prediction forecasts a potential upside of 148.8% from the current SER share price of $5.23.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.